These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21142545)

  • 1. Neoadjuvant chemotherapy or primary surgery in advanced ovarian cancer.
    Chua TC
    N Engl J Med; 2010 Dec; 363(24):2371; author reply 2372. PubMed ID: 21142545
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
    Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy or primary surgery in advanced ovarian cancer.
    Atkins CD
    N Engl J Med; 2010 Dec; 363(24):2371-2; author reply 2372. PubMed ID: 21142544
    [No Abstract]   [Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy or primary surgery in advanced ovarian cancer.
    Naito Y; Miura Y; Takano T
    N Engl J Med; 2010 Dec; 363(24):2371; author reply 2372. PubMed ID: 21142546
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
    Vergote I; Tropé CG; Amant F; Kristensen GB; Ehlen T; Johnson N; Verheijen RH; van der Burg ME; Lacave AJ; Panici PB; Kenter GG; Casado A; Mendiola C; Coens C; Verleye L; Stuart GC; Pecorelli S; Reed NS; ;
    N Engl J Med; 2010 Sep; 363(10):943-53. PubMed ID: 20818904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer.
    Rosen B; Laframboise S; Ferguson S; Dodge J; Bernardini M; Murphy J; Segev Y; Sun P; Narod SA
    Gynecol Oncol; 2014 Sep; 134(3):462-7. PubMed ID: 25026637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of ovarian carcinoma.
    Kehoe S
    Minerva Ginecol; 2008 Apr; 60(2):155-64. PubMed ID: 18487966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced cytoreductive surgery in gynecologic oncology.
    Bristow RE
    Gynecol Oncol; 2009 Aug; 114(2 Suppl):S1-2. PubMed ID: 19573698
    [No Abstract]   [Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy or primary surgery in advanced ovarian cancer.
    Naik R; Barton DP
    N Engl J Med; 2010 Dec; 363(24):2370-1; author reply 2372. PubMed ID: 21142547
    [No Abstract]   [Full Text] [Related]  

  • 10. Peritoneal tuberculosis simulating advanced ovarian carcinoma: is clinical impression sufficient to administer neoadjuvant chemotherapy for advanced ovarian cancer?
    Gurbuz A; Karateke A; Kabaca C; Kir G; Cetingoz E
    Int J Gynecol Cancer; 2006; 16 Suppl 1():307-12. PubMed ID: 16515610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.
    Favero G; Macerox N; Pfiffer T; Köhler C; da Costa Miranda V; Estevez Diz Mdel P; Fukushima JT; Baracat EC; Carvalho JP
    Oncology; 2015; 89(3):159-66. PubMed ID: 25968072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of Iranian patients with advanced ovarian cancer with neoadjuvant chemotherapy versus primary debulking surgery.
    Ghaemmaghami F; Karimi-Zarchi M; Modares-Gilani M; Mousavi A; Behtash N
    Asian Pac J Cancer Prev; 2008; 9(4):719-24. PubMed ID: 19256766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The next steps in improving the outcomes of advanced ovarian cancer.
    Openshaw MR; Fotopoulou C; Blagden S; Gabra H
    Womens Health (Lond); 2015 Jun; 11(3):355-67. PubMed ID: 26102473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting surgical outcome for advanced ovarian cancer, surgical standards of care, and the concept of kaizen.
    Bristow RE
    Gynecol Oncol; 2009 Jan; 112(1):1-3. PubMed ID: 19100914
    [No Abstract]   [Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.
    Vergote IB; De Wever I; Decloedt J; Tjalma W; Van Gramberen M; van Dam P
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):31-6. PubMed ID: 10952124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The position of neoadjuvant chemotherapy within the treatment of ovarian cancer.
    Van Gorp T; Amant F; Neven P; Berteloot P; Leunen K; Vergote I
    Minerva Ginecol; 2006 Oct; 58(5):393-403. PubMed ID: 17006426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions.
    Onda T; Yoshikawa H
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):1053-67. PubMed ID: 21806329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ovarian cancer treatment from the standpoint of the gynecologic oncologist].
    Sugiyama T; Yoshizaki A; Hatayama S
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1011-6. PubMed ID: 17637537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer.
    Morice P; Dubernard G; Rey A; Atallah D; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D
    J Am Coll Surg; 2003 Dec; 197(6):955-63. PubMed ID: 14644284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year results of cyclic semi-high dose neoadjuvant chemotherapy supported by autologous peripheral blood stem-cell transplantation in patients with advanced ovarian cancer.
    Ikeba K; Okubo M; Takeda S; Kinoshita K; Maeda H
    Int J Clin Oncol; 2004 Apr; 9(2):113-9. PubMed ID: 15108043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.